Now showing items 1-2 of 2

  • Proctitis following stereotactic body radiation therapy for prostate cancer 

    Joh, Daniel Y.; Chen, Leonard N.; Porter, Gerald; Bhagat, Aditi; Sood, Sumit; Kim, Joy S.; Moures, Rudy; Yung, Thomas; Lei, Siyuan; Collins, Brian T.; Ju, Andrew Wenhua; Suy, Simeng; Carroll, John; Lynch, John H.; Dritschilo, Anatoly; Collins, Sean P. (2014-12)
    Background Proctitis after radiation therapy for prostate cancer remains an ongoing clinical challenge and critical quality of life issue. SBRT could minimize rectal toxicity by reducing the volume of rectum receiving ...
  • Yttrium-90 Radioembolization in Patients with Hepatocellular Carcinoma Who have Previously Received Sorafenib 

    Rana, Nitesh; Ju, Andrew Wenhua; Bazylewicz, Michael; Kallakury, Bhaskar; He, Aiwu Ruth; Unger, Keith R.; Lee, Justin S. (2013-11)
    Purpose: Yttrium-90 radioembolization (RE) is a locoregional therapy option for hepatocellular carcinoma (HCC). Sorafenib is a multikinase inhibitor used in HCC that can potentially affect the efficacy of RE by altering ...